Clinical trials

  • RUXOLITINIB for Myelofibrosis
  • BOMEDEMSTAT for Myeloproliferative neoplasms | Essential thrombocythemia | Polycythemia vera | Myelofibrosis
  • CETRELIMAB for Muscle-invasive bladder cancer (Muscle-Invasive Urothelial Carcinoma of the Bladder)
  • pembrolizumab for Non-small cell lung cancer
  • RISANKIZUMAB for Ulcerative colitis
  • INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED for Influenza | Obesity | Type 2 diabetes
  • Metformin for Bone sarcoma | Osteosarcoma | Ewing sarcoma
  • ZILTIVEKIMAB for Heart failure with mildly reduced ejection fraction (HFmrEF) | Heart failure with preserved ejection fraction (HFpEF) | Systemic inflammation
  • rapcabtagene autoleucel for B-cell lymphoma | B-cell acute leukaemia | Multiple myeloma
  • SACITUZUMAB TIRUMOTECAN for Gastroesophageal adenocarcinoma | Gastric adenocarcinoma | Esophageal adenocarcinoma
  • CARBOPLATIN for Metastatic castration-resistant prostate cancer
  • SKB264 for Advanced non-small cell lung cancer | Non-small cell lung cancer